A citation-based method for searching scientific literature

Howard I Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N Sternberg, Kurt Miller, Ronald de Wit, Peter Mulders, Kim N Chi, Neal D Shore, Andrew J Armstrong, Thomas W Flaig, Aude Fléchon, Paul Mainwaring, Mark Fleming, John D Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S de Bono. N Engl J Med 2012
Times Cited: 3063

Howard I Scher, Michael J Morris, Walter M Stadler, Celestia Higano, Ethan Basch, Karim Fizazi, Emmanuel S Antonarakis, Tomasz M Beer, Michael A Carducci, Kim N Chi, Paul G Corn, Johann S de Bono, Robert Dreicer, Daniel J George, Elisabeth I Heath, Maha Hussain, Wm Kevin Kelly, Glenn Liu, Christopher Logothetis, David Nanus, Mark N Stein, Dana E Rathkopf, Susan F Slovin, Charles J Ryan, Oliver Sartor, Eric J Small, Matthew Raymond Smith, Cora N Sternberg, Mary-Ellen Taplin, George Wilding, Peter S Nelson, Lawrence H Schwartz, Susan Halabi, Philip W Kantoff, Andrew J Armstrong. J Clin Oncol 2016
Times Cited: 735

List of shared articles

Times cited

Correlation Between Imaging-Based Intermediate Endpoints and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: Analysis of 28 Randomized Trials Using the Prostate Cancer Clinical Trials Working Group (PCWG2) Criteria in 16,511 Patients.
Sungmin Woo, Chong Hyun Suh, Andreas G Wibmer, Anton S Becker, Min Yuen Teo, Mithat Gönen, Hedvig Hricak, Howard I Scher, Michael J Morris, Hebert Alberto Vargas. Clin Genitourin Cancer 2022

Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Bethany N Smith, Rajeev Mishra, Sandrine Billet, Veronica R Placencio-Hickok, Minhyung Kim, Le Zhang, Frank Duong, Anisha Madhav, Kevin Scher, Nancy Moldawer,[...]. Mol Ther 2022

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.
Wietske I Luining, Matthijs C F Cysouw, Dennie Meijer, N Harry Hendrikse, Ronald Boellaard, André N Vis, Daniela E Oprea-Lager. Cancers (Basel) 2022

Low-Dose Enzalutamide in Metastatic Prostate Cancer-Longevity Over Conventional Survival Analysis.
Vincent Vinh-Hung, Olena Gorobets, Gilles Natchagande, Paul Sargos, Ming Yin, Nam P Nguyen, Claire Verschraegen, Edmund Folefac. Clin Genitourin Cancer 2022

The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
Renata Poteska, Kambiz Rahbar, Axel Semjonow, Andres Jan Schrader, Martin Boegemann, Katrin Schlack. BMC Cancer 2022